Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tourmaline Bio (TRML)
NASDAQ:TRML
Holding TRML?
Track your performance easily
TRML Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.12 - $48.31
Previous Close$26.04
Volume112.07K
Average Volume (3M)231.81K
Market Cap
$667.73M
Enterprise Value$386.10M
Total Cash (Recent Filing)$281.92M
Total Debt (Recent Filing)$290.00K
Price to Earnings (P/E)―
Beta2.06
Next Earnings
Mar 25, 2025EPS Estimate
-$0.88Last Dividend Ex-Date
Oct 20, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-2.82
Shares Outstanding25,642,610
10 Day Avg. Volume221,801
30 Day Avg. Volume231,813
Standard Deviation0.27
R-Squared0.15
Alpha-0.00624
Financial Highlights & Ratios
Price to Book (P/B)1.92
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.04
Forecast
1Y Price Target
$54.33Price Target Upside108.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Tourmaline Bio News
PremiumCompany Announcements
Tourmaline Bio Updates on Clinical Progress and Outlook
PremiumCompany Announcements
Tourmaline Bio Unveils Clinical Progress and New Indication
PremiumCompany Announcements
Tourmaline Bio, Inc. Reports Third Quarter Financial ResultsOwnership Overview
Currently, No data available
---
TRML FAQ
What was Tourmaline Bio’s price range in the past 12 months?
Tourmaline Bio lowest stock price was $12.12 and its highest was $48.31 in the past 12 months.
What is Tourmaline Bio’s market cap?
Currently, no data Available
When is Tourmaline Bio’s upcoming earnings report date?
Tourmaline Bio’s upcoming earnings report date is Mar 25, 2025 which is in 93 days.
How were Tourmaline Bio’s earnings last quarter?
Tourmaline Bio released its earnings results on Nov 07, 2024. The company reported -$0.78 earnings per share for the quarter, beating the consensus estimate of -$0.817 by $0.037.
Is Tourmaline Bio overvalued?
According to Wall Street analysts Tourmaline Bio’s price is currently Undervalued.
Does Tourmaline Bio pay dividends?
Tourmaline Bio pays a Notavailable dividend of $1.511 which represents an annual dividend yield of N/A. See more information on Tourmaline Bio dividends here
What is Tourmaline Bio’s EPS estimate?
Tourmaline Bio’s EPS estimate is -$0.88.
How many shares outstanding does Tourmaline Bio have?
Tourmaline Bio has 25,642,610 shares outstanding.
What happened to Tourmaline Bio’s price movement after its last earnings report?
Tourmaline Bio reported an EPS of -$0.78 in its last earnings report, beating expectations of -$0.817. Following the earnings report the stock price went up 0.949%.
Which hedge fund is a major shareholder of Tourmaline Bio?
Among the largest hedge funds holding Tourmaline Bio’s share is RA Capital Management. It holds Tourmaline Bio’s shares valued at 65M.
---
Tourmaline Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$54.33 (108.64% Upside)
$54.33 (108.64% Upside)
Hedge Fund Trend
Increased
By 1.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days <0.1%
Last 30 Days <0.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.36%
12-Months-Change
Fundamentals
Return on Equity
-27.54%
Trailing 12-Months
Asset Growth
117.43%
Trailing 12-Months
Company Description
Tourmaline Bio
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.
---
TRML Stock 12 Month Forecast
Average Price Target
$54.33
▲(108.64% Upside)
Technical Analysis
Best Analysts Covering TRML
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+44.42%
reiterated a buy rating 2 months ago
Copying Srikripa Devarakonda's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +44.42% per trade.
---